Journal article icon

Journal article

Gleason scoring varies among pathologists and this affects clinical risk in patients with prostate cancer.

Abstract:

AIMS: To investigate whether our practice of specialist review of all diagnostic biopsies was necessary to prevent misgrading of referred prostate cancer patients, and whether this misclassification, if any, would have resulted in misclassification of clinical risk grouping (Seattle Risk Grouping [SRG]) and subsequent treatment strategy and prognosis. MATERIALS AND METHODS: Important prognostic indicators for prostate cancer include the presenting prostate-specific antigen (PSA), clinical sta...

Expand abstract

Actions


Access Document


Publisher copy:
10.1016/j.clon.2005.06.011

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Surgical Sciences
Role:
Author
Expand authors...
Journal:
Clinical oncology (Royal College of Radiologists (Great Britain))
Volume:
17
Issue:
8
Pages:
655-658
Publication date:
2005-12-05
DOI:
EISSN:
1433-2981
ISSN:
0936-6555
URN:
uuid:df616c5b-8fee-4964-bd09-669f72ccdba1
Source identifiers:
414608
Local pid:
pubs:414608

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP